Both clinical and experimental studies have demonstrated that PAI-1 levels markedly increase with advancing age and contribute to the pathogenesis of multiple age-related disorders, including atherosclerosis, diabetic nephropathy, and osteoporosis. This evidence concerns the gene SERPINE1 and diabetic kidney disease.